| Structure | Chemical Name | CAS | MF |
|
(RS)-N-[1-(3-FLUOROPHENYL)ETHYL]METHYLAMINE
|
820209-02-7
|
C9H12FN
|
|
(RS)-N-[1-(2-FLUOROPHENYL)PROPYL]METHYLAMINE, 98% MIN.
|
574731-04-7
|
C10H14FN
|
|
(RS)-N-[1-(4-FLUOROPHENYL)ETHYL]METHYLAMINE, 98% MIN.
|
|
C9H12FN
|
|
(-)-(1R,3S)-N-FMOC-3-AMINOCYCLOPENTANECARBOXYLIC ACID
|
220497-67-6
|
C21H21NO4
|
|
(R,S)-N-FMOC-N'-BOC-IMIDAZOLIDINE-2-CARBOXYLIC ACID
|
207129-12-2
|
C24H26N2O6
|
|
(R,S)-N-FMOC-N'-ALLOC-(2S)-PYRROLIDINYLALANINE
|
|
C26H28N2O6
|
|
(1'R, 2'S)-NICOTINE 1,1'-DI-N-OXIDE
|
|
C10H14N2O2
|
|
(1'RS,2'S)-Nicotine 1,1'-Di-N-Oxide
|
129547-84-8
|
C10H14N2O2
|
|
R-9,T-10-DIHYDROXY-T-11,12-OXY-9,10,11,12-TETRAHYDROBENZO[C]CHRYSENE
|
139237-89-1
|
C22H16O3
|
|
+-7R,8T-DIHYDROXY-9T,-10T-EPOXY-7,8,9,10-TETRAHYDROBENZO(A.
|
58917-67-2
|
C20H14O3
|
|
R-9,T-10-DIHYDROXY-C-11,12-OXY-9,10,11,12-TETRAHYDROBENZO[C]CHRYSENE
|
139237-88-0
|
C22H16O3
|
|
(R,S)-N-1-(2-hydroxy-3-butenyl)-L-val-L-leu phenylaMide
|
|
C21H33N3O3
|
|
(R,S)-N-2-(1-HYDROXY-3-BUTENYL)-L-VALINYL-L-LEUCINYL ANILIDE
|
|
C21H33N3O3
|
|
(R,S)-N-2-(2-HYDROXY-3-BUTENYL)-L-VALINYL-L-LEUCINYL ANILIDE
|
|
C21H33N3O3
|
|
(1R,2S)-N-Isopropyl-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine
|
|
C19H23N
|
|
(2R,4S)-4-nitrobenzyl 4-Mercapto-2-((sulfaMoylaMino)Methyl)pyrrolidine-1-carboxylate
|
148017-03-2
|
C13H18N4O6S2
|
|
(1R,2S)-1-Nitro-2-phenylcyclopropane-1-carboxylic acid ethyl ester
|
|
C12H13NO4
|
|
(1R,2S)-2-Nitro-1-phenyl-1,3-propanediol diacetate
|
|
C13H15NO6
|
|
|
(1R,5S)-3β-(4-Nitrobenzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2β-carboxylic acid methyl ester
|
|
|
|
|
(1R,5S)-3β-(4-Nitrophenyl)tropane-2β-carboxylic acid methyl ester
|
|
|
|
|
(1R,6S)-7β-Nitrobicyclo[4.1.0]heptane
|
|
|
|
|
(1R,4S)-3α-Nitrobicyclo[2.2.1]hept-5-ene-2β-carbaldehyde
|
|
|
|
|
(1R,6S)-7β-Nitrobicyclo[4.1.0]heptane-7-carboxylic acid ethyl ester
|
|
|
|
|
(1R,4S)-2β-Nitrobicyclo[2.2.1]hept-5-ene-3α-carbaldehyde
|
|
|
|
Protected Imipenem
|
98367-45-4
|
C27H27N5O10S
|
|
(R,S)-1-(2-NITROPHENYL)ETHANOL
|
|
C8H9NO3
|
|
(1R,2S)-2-[(4-nitroanilino)carbonyl]cyclopropanecarboxylic acid
|
|
C11H10N2O5
|
|
(5R,6S)-4-Nitrobenzyl-3-[(2-aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-1-azabicyclo[3.2.0]hept-2-ene-7-one-2-carboxylate hydrochloride
|
442847-69-0
|
C18H21ClN3O6S-
|
|
|
(6R,7S)-11-nitro-2-azatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-triene-7-carboxylic acid
|
|
|
|
(3R,4S)-4-M-tolylpyrrolidine-3-carboxylic acid
|
|
C12H15NO2
|
|
|
rteA protein
|
142463-54-5
|
|
|
(3RS)-N-Methyl-3-phenyl-3-[2-(trifluoroMethyl)-phenoxy]propan-1-aMine Hydrochloride(2-TrifluoroMethylisoMer of Fluoxetine Hydro-chloride)
|
199188-97-1
|
C18H18F3NO2
|
|
(2R,3S)-N-(3-Methylbutyl)-3-[[N-[(2R)-3-[(phenethylamino)carbonyl]-2-[(naphthalen-1-yl)methyl]propionyl]-L-histidyl]amino]-5-methyl-2-hydroxyhexanamide
|
|
C41H54N6O5
|
|
(RS)-N-Methyl-gama-(1-naphthalenyloxy)-2-thiophenepropanamine hydrochloride
|
116817-11-9
|
C19H21NOS
|
|
(RS)-4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, [PYRIDYL-5-3H]-
|
|
C10H12N3O2T
|
|
|
rteB protein
|
142463-55-6
|
|
|
|
RS-232 MVP,DIN,W/O VALVE
|
|
|
|
|
RS-232 MVP CABLE,D89 M/F
|
|
|
|
|
RS-232 MVP CABLE,DB9,M/F,PC1
|
|
|
|
|
(20R,24S)-3β-[2-O-(D-Apio-β-D-furanosyl)-β-D-glucopyranosyloxy]-20,24-epoxy-5α-cycloartane-6α,16β,25-triol
|
|
|
|
|
rT4DNA
|
|
|
|
|
[(2R,3S)-3-[[N-(L-Valyl)-L-valyl]amino]-4-phenyl-2-hydroxybutyryl]-L-Phe-L-Val-L-Val-NH2
|
|
|
|
(RS)-N,N-diMethyl-N-(2-((4-Methylphenyl)(phenyl)Methoxy)ethyl)aMine hydrochloride
|
|
C18H24ClNO
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[m-phenylenebis(ethylene-4,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(2R,3S)-N,N-Diisopropyl-3-(phenylthio)-2-methyl(3-2H)butanamide
|
|
C17H29NOS
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[o-phenylenebis(ethylene-3,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(2R,3S)-N,N-Diisopropyl-3-(phenylthio)-2-methylbutanamide
|
|
C17H27NOS
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[o-phenylenebis(ethylene-4,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(2R,3S)-N,N-Diisopropyl-2,3-dimethyl-4-pentenamide
|
|
C13H25NO
|
|
|
(2R,3S)-N,N-Diisopropyl-2-methyl-3-phenyl(2,3-2H2)propanamide
|
|
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[p-phenylenebis(ethylene-3,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[m-phenylenebis(ethylene-3,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[ethylenebis(3,1-phenylene)]ethane-1,2-diamine
|
|
C20H22N2O2
|
|
(1R,2S)-N,N'-Diacetyl-1,2-[p-phenylenebis(ethylene-4,1-phenylene)]-1,2-ethanediamine
|
|
C28H26N2O2
|
|
(RS)-N,N-dimethyl-3-hydroxy-3-phenyl-propanamin HCl
|
|
C11H18ClNO
|
|
|
(RS)-N,N-dimethyl-3-(1-naphthloxy)-3-(2-thienyl)prpylamine oxalate
|
|
|
|
(RS)-N,N-DIMETHYL-3-HYDROXY-3-PHENYLPROPANAMINE
|
|
C11H17NO
|
|
|
(RS)-(+/-)-N,N-DIMETHYL-3-(1-NAPHTHLENYLOXY)-3-(2-THIENYL)PROPANAMINEOXALATE
|
|
|
|
(RS)-N,N-DIMETHYL-3-HYDROXY-3-(2-THIENYL)PROPANAMINE
|
|
C9H15NOS
|
|
Rs-N,N-Dimethyl-3-Hydroxy-3-(2-Thienyl)-1-Propanamine
|
|
C9H15NOS
|
|
Rs-N,N-Dimethyl-3-(1-Naphthalenyloxy)-3-(2-Thienyl)-1-PropanamineOxalate
|
|
C21H23NO5S
|
|
[R,(+)]-2-(Sodiothio)propionic acid sodium salt
|
|
C3H4Na2O2S
|
|
[R,(-)]-2-(Sodiosulfo)valeric acid sodium salt
|
|
C5H8Na2O5S
|
|
[R,(-)]-2-(Sodiosulfo)propionic acid sodium salt
|
|
C3H4Na2O5S
|
|
[R,(-)]-2-Sodiosulfohexanoic acid
|
|
C6H11NaO5S
|
|
[R,(-)]-2-(Sodiothio)valeric acid sodium salt
|
|
C5H8Na2O2S
|
|
[R,(-)]-2-(Sodiosulfo)hexanoic acid sodium salt
|
|
C6H10Na2O5S
|
|
(R,S)-N-NITROSOANATABINE
|
71267-22-6
|
C10H11N3O
|
|
(R,S)-N-NITROSOANATABINE-2,4,5,6-D4
|
1020719-69-0
|
C10H7D4N3O
|
|
(R,S)-N-Nitrosoanabasine D-Glucoside Chloride Salt
|
|
C16H24ClN3O6
|
|
(R,S)-N-NITROSOANABASINE-D4
|
1020719-68-9
|
C10H9D4N3O
|
|
(R,S)-N-NITROSOANABASINE
|
1133-64-8
|
C10H13N3O
|
|
(R,S)-N-NITROSOANABASINE
|
37620-20-5
|
C10H13N3O
|
|
|
(20R)-20-(Sodiooxysulfonyloxy)-11β,17-dihydroxy-3-oxopregna-1,4-dien-21-oic acid methyl ester
|
|
|
|
|
[R,(-)]-α-(Sodiothio)benzeneacetic acid sodium salt
|
|
|
|
[R,(-)]-2-Sodiosulfovaleric acid
|
|
C5H9NaO5S
|
|
[R,(-)]-2-(Sodiothio)hexanoic acid sodium salt
|
|
C6H10Na2O2S
|
|
[R,(+)]-2-Sodiosulfopropionic acid
|
|
C3H5NaO5S
|
|
|
[R,(-)]-α-Sodiosulfobenzeneacetic acid
|
|
|
|
(1R,1'S)-Octahydro-1-(2'-iodo-1'-Methylethyl)-7a-Methyl-inden-4-one
|
145372-32-3
|
C13H21IO
|
|
(1R,1'S)-Octahydro-1-(2'-iodo-1'-Methylethyl)-7a-Methyl-inden-4-ol
|
|
C13H23IO
|
|
|
(2R,2'S)-2,2',3,3',4,4',5,5'-Octahydro-2,2'-bifuran-5,5'-dione
|
|
|
|
|
(αR)-α-[(S)-1-(Octylamino)ethyl]-4-[(1-methylethyl)thio]benzenemethanol
|
|
|
|
(2R,3S)-4-Octadecene-1,2,3-triol 2-methanesulfonate
|
|
C19H38O5S
|
|
(2R,3S)-3-Octyl-2-oxiraneoctanoic acid isobutyl ester
|
|
C22H42O3
|
|
(R,S)-OCTYLBENZODIOXAPHOSPHORINOXIDE
|
|
C15H23O3P
|
|
(2R,5S)-N,N,N',N'-Tetramethyl-2,5-dimercaptoadipamide
|
|
C10H20N2O2S2
|
|
|
(1R,4S)-2β-[(Nonafluorobutyl)sulfonyl]-3α-(4-methoxyphenyl)bicyclo[2.2.1]hept-5-ene-2-carbonitrile
|
|
|
|
|
(1R,4S)-2β-[(Nonafluorobutyl)sulfonyl]-3α-(4-chlorophenyl)bicyclo[2.2.1]hept-5-ene-2-carbonitrile
|
|
|
|
(R,S)-Norcotinine N-Oxide
|
101708-63-8
|
C9H10N2O2
|
|
(R,S)-N-(1-Phenylethyl) Ibuprofen AMide
|
121734-79-0
|
C21H27NO
|
|
(R,S)-NORNICOTINE BITARTRATE
|
|
C17H24N2O12
|
|
|
(R,S)-NORDIHYDROGUAIARETICACID
|
|
|
|
(R,S)-NORCOTININE
|
17708-87-1
|
C9H10N2O
|
|
|
(R,S)-NORHYDROGUAIARETICACID
|
|
|
|
(R,S)-NORNICOTINE-D4
|
|
C9H8D4N2
|
|
(1R,2S)-(-)-NOREPHEDRINE-GAMMA,GAMMA,GAMMA-D3 HCL
|
352438-64-3
|
C9H14ClNO
|
|
1R,2S-(-)-Norephedrine hydrochloride
|
3198-15-0
|
C9H14ClNO
|
|
(R,S)-NORCOTININE-PYRIDYL-D4
|
1020719-70-3
|
C9H6D4N2O
|
|
(R,S)-NORCOTININE
|
|
C9H10N2O
|